Cite

HARVARD Citation

    Reslan, Z. et al. (2018). Pembrolizumab‐induced auto‐immune type‐1 diabetes in a patient with metastatic melanoma. Journal of pharmacy practice and research. pp. 262-264. [Online]. 
  
Back to record